Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

December 2011
1. MUEHLICH S , Hampl V, Khalid S, Singer S, et al
   The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
   Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. PALERMO R , Checquolo S, Giovenco A, Grazioli P, et al
   Acetylation controls Notch3 stability and function in T-cell leukemia.
   Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. TAILLER M , Senovilla L, Lainey E, Thepot S, et al
   Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.
   Oncogene. 2011 Nov 21. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SRIRAM G , Reichman C, Tunceroglu A, Kaushal N, et al
   Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
   Oncogene. 2011;30:4645-55.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. ZHENG R , Bailey E, Nguyen B, Yang X, et al
   Further activation of FLT3 mutants by FLT3 ligand.
   Oncogene. 2011;30:4004-14.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
6. ANENSEN N , Hjelle SM, Van Belle W, Haaland I, et al
   Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.
   Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
7. NAKAHATA S , Yamazaki S, Nakauchi H, Morishita K, et al
   Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.
   Oncogene. 2011;30:2900.
   PubMed     Text format     Related articles   
   
   
   
   
8. QIUPING Z , Jie X, Youxin J, Qun W, et al
   Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
   Oncogene. 2011;30:2798.
   PubMed     Text format     Related articles   
   
   
   
   
9. TAUCHI T , Okabe S, Ashihara E, Kimura S, et al
   Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen.
   Oncogene. 2011;30:2789-97.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ZHENG YS , Zhang H, Zhang XJ, Feng DD, et al
    MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
11. MOCHMANN LH , Bock J, Ortiz-Tanchez J, Schlee C, et al
    Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
    Oncogene. 2011;30:2044-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ALTMAN BJ , Jacobs SR, Mason EF, Michalek RD, et al
    Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis.
    Oncogene. 2011;30:1855-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
13. GAO XN , Lin J, Li YH, Gao L, et al
    MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
14. VON BUBNOFF N , Gorantla SP, Engh RA, Oliveira TM, et al
    The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro.
    Oncogene. 2011;30:933-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. DETTMAN EJ , Simko SJ, Ayanga B, Carofino BL, et al
    Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
16. HE H , Hua X, Yan J
    Epigenetic regulations in hematopoietic Hox code.
    Oncogene. 2011;30:379-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. DE CARVALHO DD , Binato R, Pereira WO, Leroy JM, et al
    BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
    Oncogene. 2011;30:223-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
18. QUEIROZ KC , Ruela-de-Sousa RR, Fuhler GM, Aberson HL, et al
    Hedgehog signaling maintains chemoresistance in myeloid leukemic cells.
    Oncogene. 2010;29:6314-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
19. MATSUOKA M , Jeang KT
    Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. RABSON AB
    Trisomy 21 leukemias: finding the hits that matter.
    Oncogene. 2010;29:6099-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. DE VITA S , Canzonetta C, Mulligan C, Delom F, et al
    Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
    Oncogene. 2010;29:6102-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MAJETI R
    Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. LI Q , He Y, Wei L, Wu X, et al
    AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. DRAHEIM KM , Hermance N, Yang Y, Arous E, et al
    A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
25. ORAM SH , Thoms JA, Pridans C, Janes ME, et al
    A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oncogene. 2010;29:5796-808.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. QIU JJ , Chu H, Lu X, Jiang X, et al
    The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TONINO SH , van Laar J, van Oers MH, Wang JY, et al
    ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
28. WEISBERG E , Sattler M, Ray A, Griffin JD, et al
    Drug resistance in mutant FLT3-positive AML.
    Oncogene. 2010;29:5120-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. TROMP JM , Tonino SH, Elias JA, Jaspers A, et al
    Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Oncogene. 2010;29:5071-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
30. YOUSEF AF , Fonseca GJ, Pelka P, Ablack JN, et al
    Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation.
    Oncogene. 2010;29:4693-704.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
31. ALBERO MP , Vaquer JM, Andreu EJ, Villanueva JJ, et al
    Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells.
    Oncogene. 2010;29:3276-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: